David Thomas, MD
Surgery · San Antonio, TXNPI 1942449707
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Standard Bariatrics, Inc. at 47.2% of the total. Reporting peaked in 2022 at $22,418 and has fallen 91.9% since, to $1,816 in 2025. Among surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $247.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Standard Bariatrics, Inc.$18K
- Intuitive Surgical$12K
- Davol Inc.$3K
- Medtronic$2K
- Medical Device Business Services, Inc.$1K
- Covidien LP$656
- plus $403 from 10 others
What the payments were for
- Consulting fees$13,50036%
- Speaking & faculty fees$5001%
- Travel & lodging$9,07724%
- Food & beverage$5,95216%
- Education$8,53223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Standard Bariatrics, Inc. | 23 | $17,730 |
| Intuitive Surgical | 49 | $12,406 |
| Davol Inc. | 31 | $3,131 |
| Medtronic | 15 | $1,929 |
| Medical Device Business Services, Inc. | 7 | $1,306 |
| Covidien LP | 9 | $656 |
| Johnson & Johnson | 8 | $167 |
| BD | 1 | $58 |
| Procept Biorobotics Corporation | 1 | $41 |
| Vivus LLC | 2 | $40 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $14 |
| Lexington Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN SGS STANDARD GASTRIC STAPLER$17,242
- Da Vinci Surgical System$8,033
- DAVINCI XI$3,000
- LINX Reflux Management System$1,228
- Signia$1,179
- Phasix Mesh$953
- LigaSure$365
- iDrive$150
- Endo GIA$150
- PHASIX$130
- EndoFlip$128
How this compares
$37,561 in reported general payments places this provider in the 90th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 58 | $69,177 |
| Sucralfate | 12 | $950 |
| Ondansetron OdtOndansetron | 57 | $821 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $203 |
| Pantoprazole Sodium | 36 | $188 |
| Promethazine Hcl | 15 | $74 |
| Ondansetron Hcl | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $18 | $69,17758 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,830 surgery providers in Texas.
Other surgery in San Antonio
- Richard PetersonSan Antonio$323K
- Joseph KaramSan Antonio$293K
- John PilcherSan Antonio$214K
- John MeterskySan Antonio$158K
- Kent van SickleSan Antonio$143K
- Richard EnglehardtSan Antonio$107K
- Guillermo Portillo RamilaSan Antonio$102K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.